Prognostic significance of EGFR, MUC1 and PD-L1 expressions in cases with triple negative breast cancer

MİRİLİ C., PAYDAŞ S., BAĞIR KILIÇ E., SEYDAOĞLU G., OĞUL A., GÖKÇAY S., ...Daha Fazla

JOURNAL OF BUON, cilt.25, sa.1, ss.159-167, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 1
  • Basım Tarihi: 2020
  • Dergi Adı: JOURNAL OF BUON
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.159-167
  • Anahtar Kelimeler: EGFR, MUC1, PD-L1, triple negative breast cancer, prognosis, TUMOR-INFILTRATING LYMPHOCYTES, CLINICAL-FEATURES, ONCOPROTEIN, ACTIVATION, MUCINS, CARCINOMA, SURVIVAL
  • Çukurova Üniversitesi Adresli: Evet

Özet

Purpose: Twenty percent of the breast cancers are triple negative (TNBC). Despite the impressive progression in the biology of this subgroup, data is limited as compared to hormone and/or HER2 positive cases. Thus, the aim of this study was to detect the expression levels and to identify the prognostic values of MUC1, EGFR and PD-L1 in TNBC.